ABSTRACT The effect of nebulised salbutamol on the bronchial response to nebulised histamine was studied in five wheezy infants aged 3-12 months. The response to doubling concentrations of up to 8 g/l of histamine was assessed by the change in maximum flow at FRC (VmaxFRc), measured by flow-volume curves produced during forced expiration with a pressure jacket. The concentration of histamine required to provoke a 30% fall in VmaxFRc (PC30) was measured. All of the infants responded to low concentrations of histamine during control tests before and after nebulised saline (mean PC30 1 07 and 0-51 g/l). On a separate day there was a similar response to histamine before salbutamol (PC30 0 57 g/l), but after salbutamol the response was completely abolished up to the maximum concentration of histamine in all subjects (PC30 > 8 g/1). Thus wheezy infants have highly effective P2 adrenoceptors in intrathoracic airways.
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Wheezing disorders of infancy, although common, are difficult to treat.1 Physiological studies carried out on wheezy infants have failed to show any useful response to nebulised f adrenergic agents in terms of reduction in the overall respiratory resistance or work of breathing.2`Since, however, in infants more than 50% of total airway resistance is contributed by the upper airways, a change in intrathoracic airway calibre may well be masked in this type of study. In a recent study of airway responsiveness to salbutamol in wheezy infants we used a pressure jacket to produce partial expiratory flow-volume (PEFV) curves. From these curves we determined forced expiratory flow at FRC (VmaxFRc) as an index of intrathoracic airway function. In common with others5 -7we found a significant fall in VmaXFRc after nebulised salbutamol. Although negative, this observation supports the concept that ,B receptors are present in the infant airway in sufficient density to be recognisable by gross physiological measurements. A possible explanation for this paradoxical response to a "bronchodilator" drug is that a reduction in smooth muscle tone, without a commensurate fall in airway resistance, renders the airways more compliant and therefore less able to support high flow rates.8
Although little information is available pertaining to the human infant airway, / adrenergic receptors have been shown to be present and functional in airway preparations of other infant mammals. 9 10 We have recently shown that the intrathoracic airways of wheezy infants are capable of an acute and spontaneously reversible response to nebulised histamine."1 Given an appropriate stimulus therefore, the infant airway can respond acutely, although the site and mechanism of the response is conjectural. In older subjects the bronchial response to histamine can be very effectively blocked by the administration of nebulised / adrenergic drugs.12 In the present study we measured the degree of protection against histamine induced airway obstruction afforded by nebulised salbutamol as an index of ,B adrenergic responsiveness. In this way we hoped to determine whether functional / adrenoceptors are present in the human infant airway.
Methods

SUBJECTS
Five recurrently wheezy infants were studied at a mean age of 6-8 months (range 3-12 months). Four of the infants had a first degree family history of asthma, three had a history of eczema, and four had parents who smoked. The history of wheezing ranged from one to eight months and the attacks were intermittent. The interval between attacks varied from 24 Differences between values following salbutamol and saline administration were compared by the paired t test. PC30 values were subjected to log transformation before statistical analysis.
Results
Baseline values of sRaw were appreciably raised on only three of the 10 study days, whereas values of VmaxFRc were much lower than reference values on seven study days (table 1) . Both the saline control solution and salbutamol had variable effects on the level of airway obstruction (table 2) . There was a tendency for VmaxFRc to decline after saline, although only in one subject (No 2) was the effect considerable. Salbutamol had no net effect, although in one subject (No 4) there was a striking improvement in VmaxFRc.
All five subjects responded to histamine (table 3) . There was a clear response before and after the con- figure) . This response was highly significant. After salbutamol there was no significant change in Individual response curves on the salbutamol study day. The fact that in this and in a previous study' we found, as have many others before us2-4 that baseline lung function did not improve after bronchodilators suggests that there may be a difference between the mechanisms causing chronic airway narrowing in wheezy infants and the mechanism of the acute response to an irritant trigger, represented in this study by the histamine challenge. Before we suggest reasons for this discrepancy some technical points need consideration.
The histamine challenge test that we have described" is modified from a well standardised technique for older subjects. By using flow-volume curves the response to histamine can be localised to intrathoracic airways. This is important since nebulised drugs administered to sleeping infants must be preferentially deposited in the nasal passages, and they may have their major physiological effect there. Indeed, some of the intrathoracic effects of histamine may be indirectly mediated by neural reflexes originating in the nose. '8 Only if this were the complete explanation for the intrathoracic effect of histamine, which is unlikely, could the blocking effect of salbutamol be explained by a local effect in the nose.
The design of the studies represents a compromise imposed by the need to complete a set of observations within a single period of sleep (up to 2-3 hours). This allowed only a 30 minute recovery period after the first histamine challenge test and a 15 minute period after nebulisation of the bronchodilator. Recovery following the first histamine test was incomplete in some infants (table 2) , and this may explain the fact that reproducibility of histamine responsiveness was poorer than in older children."9 A 15 minute period after administration is normally sufficient time for nebulised bronchodilator drugs to achieve their maximum protective effect against histamine challenge in older subjects, after which the beneficial effect wears off rapidly."2 The very striking effect of salbutamol on histamine response in our infants cannot easily be explained by the design of the study. Although in older subjects increased bronchial responsiveness to histamine cannot be directly equated with clinical asthma, much has been learned about airway pathophysiology, clinical management, and the clinical epidemiology of asthma by the study of bronchial responsiveness. There are clearly great differences between wheezy infants and asthmatic children, the most obvious being the difference in the response to /B adrenergic agents. The fact that histamine responsiveness is common to the two groups, however, suggests that the differences may be in quantity, and not in quality. The evidence from this study suggests that, while reversible airways obstruction may occur in wheezy infants, it does so against a background of airway narrowing unresponsive to bronchodilators. This "fixed" obstruction may be inflammatory or secretory in nature. In such circumstances airway smooth muscle tone may be helping to "splint" the airways. A reduction in such tone would then cause impairment of airway function, especially during forced expiration.5'8
The improvement in maximum flows that was seen with low concentrations of histamine after nebulised salbutamol (figure) has not previously been reported. Histamine seems to be exerting two effects on the airway, one of which is to cause airway obstruction and 104 a fall in VmaxFRc, and this is blocked by salbutamol.
The other is to improve maximum expiratory flows, and this is not blocked by salbutamol. In theory, the latter effect could be brought about by a small decline in airway compliance, perhaps by an increase in airway smooth muscle "tone" or a minor vascular effect. We have no evidence for this, although we The results of this study provide strong evidence for the presence of effective functional P2 receptors in the infant airway, in sufficient quantity to protect against a non-specific challenge. Their density and distribution cannot be determined from a study such as this and will require the use of autoradiographic techniques. Evidence on the role of adrenergic agents in the treatment of infantile asthma remains equivocal. The importance of the present study is not in its immediate clinical application but in the approach that it provides to the study of airway function in wheezy infants. It is hoped that by techniques similar to those described here the pathogenesis and natural history of wheezing disorders in infancy can be studied safely.
